Brian J. Polizzi

Statistics

Publications

Citations

545

H-Index

Active since

2002

Affiliations

GlaxoSmithKline (United States)(Current)

South College

GlaxoSmithKline (United Kingdom)

Brian J. Polizzi is an author at GlaxoSmithKline (United States) specializing in bacterial fatty acid biosynthesis, novel antibacterial drug discovery, and enzyme inhibition.

Publications per year

2002–2003

Publications

Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents

David Payne, William H. Miller, Valerie Berry et al. · Antimicrobial Agents and Chemotherapy · 2002 · 165 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK

Mark A. Seefeld, William H. Miller, Kenneth A. Newlander et al. · Journal of Medicinal Chemistry · 2003 · 161 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI)

William H. Miller, Mark A. Seefeld, Kenneth A. Newlander et al. · Journal of Medicinal Chemistry · 2002 · 110 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK)

Hédia Marrakchi, Walter E. DeWolf, Chad Quinn et al. · Biochemical Journal · 2003 · 109 citations · Full text

Life Sciences, Biochemistry, Microbiology +16

1–4 of 4